These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1409741)

  • 1. Down syndrome as a key to the time sequence of brain changes in Alzheimer disease.
    Tagliavini F; Giaccone G; Verga L; Frangione B; Bugiani O
    Prog Clin Biol Res; 1992; 379():143-58. PubMed ID: 1409741
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 3. A molecular approach to Alzheimer's disease.
    Multhaup G; Masters CL; Beyreuther K
    Biol Chem Hoppe Seyler; 1993 Jan; 374(1):1-8. PubMed ID: 8439394
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal models of the neuropathology observed in Alzheimer's disease and Down syndrome.
    Richards SJ; Edwards P; Dunnett SB
    Prog Clin Biol Res; 1992; 379():245-58. PubMed ID: 1409748
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relation between Down's syndrome and Alzheimer-type dementia].
    Steffelaar JW; Bots GT; Evenhuis HM
    Ned Tijdschr Geneeskd; 1988 Aug; 132(33):1516-7. PubMed ID: 2971883
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease.
    von Gunten A; Miklossy J; Suvà ML; Hof PR; Giannakopoulos P
    J Neurol; 2004 Jun; 251(6):750-2. PubMed ID: 15311354
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary characterization of long-term reaggregating cultures of trisomy 16 central nervous system.
    Bredesen DE; Kane DJ; Holtzman DM; Epstein CJ
    Prog Clin Biol Res; 1992; 379():259-70. PubMed ID: 1409749
    [No Abstract]   [Full Text] [Related]  

  • 12. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta protein and Alzheimer disease.
    Square D
    CMAJ; 1997 Apr; 156(7):1040-2. PubMed ID: 9099177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity.
    Kametani F; Tanaka K; Ishii T; Ikeda S; Kennedy HE; Allsop D
    Biochem Biophys Res Commun; 1993 Mar; 191(2):392-8. PubMed ID: 8460999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer disease and Down syndrome: factors in pathogenesis.
    Lott IT; Head E
    Neurobiol Aging; 2005 Mar; 26(3):383-9. PubMed ID: 15639317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences.
    Bateman DA; Chakrabartty A
    Biopolymers; 2004; 76(1):4-14. PubMed ID: 14997469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in APP and their role in beta-amyloid deposition.
    Fidani L; Goate A
    Prog Clin Biol Res; 1992; 379():195-214. PubMed ID: 1409745
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.